Role of neurotrophins in neuropathic pain

Current Neuropharmacology

Volumn 9, Issue 4, 2011, Pages 523-529

  Siniscalco, Dario ^a   Giordano, Catia ^a   Rossi, Francesco ^a   Maione, Sabatino ^a   de Novellis, Vito ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

BDNF; Neuropathic pain; Neurotrophins; NGF; NT 3; NT 4

Indexed keywords

ANTICONVULSIVE AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE NT3; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMAZEPINE; DEXTROMETHORPHAN; GABAPENTIN; LAMOTRIGINE; LEVACECARNINE; LIDOCAINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MNAC13; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PEPTIDE; PROTEIN TYROSINE KINASE A; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ALLODYNIA; ANALGESIA; ARTICLE; CELL DEATH; CELL SURVIVAL; DEPRESSION; DIABETIC NEUROPATHY; GENE EXPRESSION; HUMAN; HYPERALGESIA; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; PROTEIN FUNCTION; WELLBEING;

EID: 82955249792     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015911798376208     Document Type: Article

References (76)

1. Levi-Montalcini, R. Tissue and nerve growth promoting factors. Biological aspects of specific growth promoting factors. Proc. R. Soc. Med., 1965, 58, 357-360.
2. Oppenheim, R.W.; Qin-Wei, Y.; Prevette, D.; Yan, Q. Brainderived neurotrophic factor rescues developing avian moto-neurons from cell death. Nature, 1992, 350, 755-757.
3. Finkbeiner, S.; Tavazoie, S.F.; Maloratsky, A.; Jacobs, K.M.; Harris, K.M.; Greenberg, E. CREB: a major mediator of neuronal neurotrophin responses. Neuron, 1997, 19, 1031-1047.
4. Patapoutian, A.; Reichardt, L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol., 2001, 11(3), 272 280.
5. Klein, R.; Jing, S.Q.; Nanduri, V.; O'Rourke, E.; Barbacid, M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell, 1991, 65(1), 189-197.
6. Kaplan, D.R.; Stephens, R.M. Neurotrophin signal transduction by the Trk receptor. J. Neurobiol. 1994, 25, 1404-1417.
7. D'Arcangelo, G.; Halegoua, S. A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell. Biol 1993, 13, 3146-3155.
8. Bonni, A.; Ginty, D.D.; Dudek, H.; Greenberg, M.E. Serine 133 phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol. Cell Neurosci., 1995, 6, 168-183.
9. Eibl, J.K.; Chapelsky, S.A.; Ross, G.M. Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor. J. Pharmacol. Exp. Ther., 2010, 332(2), 446-454.
10. Merskey, H.; Bogduk, N. Classification of chronic pain; IASP press: Seattle, 1994.
11. Siniscalco, D.; Giordano, C.; Galderisi, U.; Luongo, L.; Alessio, N.; Di Bernardo, G.; de Novellis, V.; Rossi, F.; Maione, S. Intrabrain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol. Life Sci., 2010, 67(4), 655-669.
12. de Novellis, V.; Siniscalco, D.; Galderisi, U.; Fuccio, C.; Nolano, M.; Santoro, L.; Cascino, A.; Roth, K.A.; Rossi, F.; Maione, S. Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II. Neuropharmacology, 2004, 46(4), 468-479.
13. Siniscalco, D.; Giordano, C.; Fuccio, C.; Luongo, L.; Ferraraccio, F.; Rossi, F.; de Novellis, V.; Roth, K.A.; Maione, S. Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats. Pharmacol. Res., 2008, 57(3), 223-233.
14. Siniscalco, D.; Rossi, F.; Maione, S. Molecular approaches for neuropathic pain treatment. Curr. Med. Chem., 2007, 14(16), 1783-1787.
15. Stein, C.; Clark, J.D.; Oh, U.; Vasko, M.R.; Wilcox, G.L.; Overland, A.C.; Vanderah, T.W.; Spencer, R.H. Peripheral mechanisms of pain and analgesia. Brain Res. Rev., 2009, 60(1), 90-113.
16. Covey, W.C.; Ignatowski, T.A.; Knight, P.R.; Spengler, R.N. Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Res., 2000, 859(1), 113-122.
17. Cervero, F.; Laird, J.M. Role of ion channels in mechanisms controlling gastrointestinal pain pathways. Curr. Opin. Pharmacol., 2003, 3(6), 608-612.
18. Black, J.A.; Langworthy, K.; Hinson, A.W.; Dib-Hajj, S.D.; Waxman, S.G. NGF has opposing effects on Na+ channel III and SNS gene expression in spinal sensory neurons. Neuroreport, 1997, 8(9-10), 2331-2335.
19. Marabese, I.; de Novellis, V.; Palazzo, E.; Mariani, L.; Siniscalco, D.; Rodella, L.; Rossi, F.; Maione, S. Differential roles of mGlu8 receptors in the regulation of glutamate and gamma-aminobutyric acid release at periaqueductal grey level. Neuropharmacology, 2005, 49(Suppl 1), 157-166.
20. Coderre, T.J.; Katz, J.; Vaccarino, A.L.; Melzack, R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain, 1993, 52(3), 259-285.
21. Jasmin, L.; Rabkin, S.D.; Granato, A.; Boudah, A.; Ohara, P.T. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature, 2003, 424(6946), 316-320.
22. Maione, S.; Siniscalco, D.; Galderisi, U.; de Novellis, V.; Uliano, R.; Di Bernardo, G.; Berrino, L.; Cascino, A.; Rossi, F. Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat. Neuroreport, 2002, 13(1), 101-106.
23. Dworkin, R.H.; O'Connor, A.B.; Backonja, M.; Farrar, J.T.; Finnerup, N.B.; Jensen, T.S.; Kalso, E.A.; Loeser, J.D.; Miaskowski, C.; Nurmikko, T.J.; Portenoy, R.K.; Rice, A.S.; Stacey, B.R.; Treede, R.D.; Turk, D.C.; Wallace, M.S. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain, 2007, 132(3), 237-251.
24. Shu, X.Q.; Mendell, L.M. Neurotrophins and hyperalgesia. Proc. Natl. Acad. Sci. USA, 1999, 96(14), 7693-7696.
25. Anand, P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog. Brain Res., 2004, 146, 477-492.
26. Obata, K.; Noguchim, K. BDNF in sensory neurons and chronic pain. Neurosci. Res., 2006, 55(1), 1-10.
27. Marcol, W.; Kotulska, K.; Larysz-Brysz, M.; Kowalik, J.L. BDNF contributes to animal model neuropathic pain after peripheral nerve transection. Neurosurg. Rev., 2007, 30(3), 235-243.
28. Wild, K.D.; Bian, D.; Zhu, D.; Davis, J.; Bannon, A.W.; Zhang, T.J.; Louis, J.C. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J. Pharmacol. Exp. Ther., 2007, 322(1), 282 287.
29. Sato, C.; Sakai, A.; Ikeda, Y.; Suzuki, H.; Sakamoto, A. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain. Anesth. Analg., 2008, 106(1), 313-320.
30. Herzberg, U.; Eliav, E.; Dorsey, J.M.; Gracely, R.H.; Kopin, I.J. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport, 1997, 8(7), 1613-1618.
31. Ozaki, Y.; Kitamura, N.; Tsutsumi, A.; Dayanithi, G.; Shibuya, I. NGF-induced hyperexcitability causes spontaneous fluctuations of intracellular Ca2+ in rat nociceptive dorsal root ganglion neurons. Cell Calcium, 2009, 45(3), 209-215.
32. Taiwo, Y.O.; Levine, J.D.; Burch, R.M.; Woo, J.E.; Mobley, W.C. Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. Proc. Natl. Acad. Sci. USA, 1991, 88(12), 5144-5148.
33. Svensson, P.; Cairns, B.E.; Wang, K.; Arendt-Nielsen, L. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain, 2003, 104(1-2), 241-247.
34. Wilson-Gerwing, T.D.; Stucky, C.L.; McComb, G.W.; Verge, V.M. Neurotrophin-3 significantly reduces sodium channel expression linked to neuropathic pain states. Exp. Neurol., 2008, 213(2), 303-314.
35. Vivoli, E.; Di Cesare Mannelli, L.; Salvicchi, A.; Bartolini, A.; Koverech, A.; Nicolai, R.; Benatti, P.; Ghelardini, C. Acetyl-lcarnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy. Neuroscience, 2010, 167(4), 1168-1174.
36. Jing, Y.Y.; Wang, J.Y.; Li, X.L.; Wang, Z.H.; Pei, L.; Pan, M.M.; Dong, X.P.; Fan, G.X.; Yuan, Y.K. Nerve growth factor of red nucleus involvement in pain induced by spared nerve injury of the rat sciatic nerve. Neurochem. Res., 2009, 34(9), 1612-1618.
37. Chien, C.C.; Fu, W.M.; Huang, H.I.; Lai, Y.H.; Tsai, Y.F.; Guo, S.L.; Wu, T.J.; Ling, Q.D. Expression of neurotrophic factors in neonatal rats after peripheral inflammation. J. Pain, 2007, 8(2), 161-167.
38. Lindsay, R.M.; Harmar, A.J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature, 1989, 337(6205), 362-364.
39. Winston, J.; Toma, H.; Shenoy, M.; Pasricha, P.J. Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain, 2001, 89(2-3), 181-186.
40. Fang, X.; Djouhri, L.; McMullan, S.; Berry, C.; Okuse, K.; Waxman, S.G.; Lawson, S.N. TrkA is expressed in nociceptive neurons and influences electrophysiological properties via Nav1.8 expression in rapidly conducting nociceptors. J. Neurosci., 2005, 25, 4868-4878.
41. Mousa, S.A.; Cheppudira, B.P.; Shaqura, M.; Fischer, O.; Hofmann, J.; Hellweg, R.; Schäfer, M. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain, 2007, 130(Pt 2), 502-513.
42. Xie, W.; Strong, J.A.; Zhang, J.M. Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models. Neuroscience, 2009, 160(4), 847-857.
43. Zhou, X.F.; Deng, Y.S.; Chie, E.; Xue, Q.; Zhong, J.H.; McLachlan, E.M.; Rush, R.A.; Xian, C.J. Satellite-cell-derived nerve growth factor and neurotrophin-3 are involved in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve injury in the rat. Eur. J. Neurosci., 1999, 11(5), 1711-1722.
44. Wu, C.; Boustany, L.; Liang, H.; Brennan, T.J. Nerve growth factor expression after plantar incision in the rat. Anesthesiology, 2007, 107(1), 128-135.
45. Hefti, F.F.; Rosenthal, A.; Walicke, P.A.; Wyatt, S.; Vergara, G.; Shelton, D.L.; Davies, A.M. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci., 2006, 27(2), 85-91.
46. Watson, J.J.; Allen, S.J.; Dawbarn, D. Targeting nerve growth factor in pain: what is the therapeutic potential? BioDrugs, 2008, 22(6), 349-359.
47. Sabsovich, I.; Wei, T.; Guo, T.Z.; Zhao, R.; Shi, X.; Li, X.; Yeomans, D.C.; Klyukinov, M.; Kingery, W.S.; Clark, J.D. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain, 2008, 138(1), 47-60.
48. Hongo, J.S.; Laramee, G.R.; Urfer, R.; Shelton, D.L.; Restivo, T.; Sadick, M.; Galloway, A.; Chu, H.; Winslow, J.W. Antibody binding regions on human nerve growth factor identified by homolog and alanine-scanning mutagenesis. Hybridoma, 2000, 19(3), 215-227.
49. Ugolini, G.; Marinelli, S.; Covaceuszach, S.; Cattaneo, A.; Pavone, F. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl. Acad. Sci. USA, 2007, 104(8), 2985-2990.
50. Summer, G.J.; Puntillo, K.A.; Miaskowski, C.; Dina, O.A.; Green, P.G.; Levine, J.D. TrkA and PKC-epsilon in thermal burn-induced mechanical hyperalgesia in the rat. J. Pain, 2006, 7(12), 884-891.
51. Owolabi, J.B.; Rizkalla, G.; Tehim, A.; Ross, G.M.; Riopelle, R.J.; Kamboj, R.; Ossipov, M.; Bian, D.; Wegert, S.; Porreca, F.; Lee, D.K. Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J. Pharmacol. Exp. Ther., 1999, 289(3), 1271-1276.
52. Cirillo, G.; Cavaliere, C.; Bianco, M.R.; De Simone, A.; Colangelo, A.M.; Sellitti, S.; Alberghina, L.; Papa, M. Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain. Cell Mol. Neurobiol., 2010, 30(1), 51-62.
53. Colangelo, A.M.; Bianco, M.R.; Vitagliano, L.; Cavaliere, C.; Cirillo, G.; De Gioia, L.; Diana, D.; Colombo, D.; Redaelli, C.; Zaccaro, L.; Morelli, G.; Papa, M.; Sarmientos, P.; Alberghina, L.; Martegani, E. A new nerve growth factor-mimetic peptide active on neuropathic pain in rats. J. Neurosci., 2008, 28(11), 2698-2709.
54. McArthur, J.C.; Yiannoutsos, C.; Simpson, D.M.; Adornato, B.T.; Singer, E.J.; Hollander, H.; Marra, C.; Rubin, M.; Cohen, B.A.; Tucker, T.; Navia, B.A.; Schifitto, G.; Katzenstein, D.; Rask, C.; Zaborski, L.; Smith, M.E.; Shriver, S.; Millar, L.; Clifford, D.B. A phase II trial of recombinant human nerve growth factor for sensory neuropathy associated with HIV infection. Neurology, 2000, 54, 1080-1088.
55. Geng, S.J.; Liao, F.F.; Dang, W.H.; Ding, X.; Liu, X.D.; Cai, J.; Han, J.S.; Wan, Y.; Xing, G.G. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation. Exp. Neurol., 2010, 222(2), 256-266.
56. Li, L.; Xian, C.J.; Zhong, J.H.; Zhou, X.F. Upregulation of brainderived neurotrophic factor in the sensory pathway by selective motor nerve injury in adult rats. Neurotox. Res., 2006, 9(4), 269 283.
57. Wang, X.; Ratnam, J.; Zou, B.; England, P.M.; Basbaum, A.I. TrkB signaling is required for both the induction and maintenance of tissue and nerve injury-induced persistent pain. J. Neurosci., 2009, 29(17), 5508-5515.
58. Yajima, Y.; Narita, M.; Narita, M.; Matsumoto, N.; Suzuki, T. Involvement of a spinal brain-derived neurotrophic factor/fulllength TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice. Brain Res., 2002, 958(2), 338-346.
59. Cragg, J.J.; Scott, A.L.; Ramer, M.S. Depletion of spinal 5-HT accelerates mechanosensory recovery in the deafferented rat spinal cord. Exp. Neurol., 2010, 222(2), 277-284.
60. Hayashida, K.; Clayton, B.A.; Johnson, J.E.; Eisenach, J.C. Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain, 2008, 136(3), 348-355.
61. Ciobanu, C.; Reid, G.; Babes, A. Acute and chronic effects of neurotrophic factors BDNF and GDNF on responses mediated by thermo-sensitive TRP channels in cultured rat dorsal root ganglion neurons. Brain Res., 2009, 1284, 54-67.
62. Dray, A. Neuropathic pain: emerging treatments. Br. J. Anaesth., 2008, 101(1), 48-58.
63. Ulmann, L.; Hatcher, J.P.; Hughes, J.P.; Chaumont, S.; Green, P.J.; Conquet, F.; Buell, G.N.; Reeve, A.J.; Chessell, I.P.; Rassendren, F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci., 2008, 28(44), 11263-11268.
64. Fujita, R.; Ma, Y.; Ueda, H. Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia. J. Neurochem., 2008, 107(1), 152-160.
65. Quintão, N.L.; Santos, A.R.; Campos, M.M.; Calixto, J.B. The role of neurotrophic factors in genesis and maintenance of mechanical hypernociception after brachial plexus avulsion in mice. Pain, 2008, 136(1-2), 125-133.
66. Eaton, M.J.; Blits, B.; Ruitenberg, M.J.; Verhaagen, J.; Oudega, M. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated overexpression of BDNF in the rat spinal cord. Gene Ther., 2002, 9(20), 1387-1395.
67. Kobayashi, M.; Matsuoka, I. Enhancement of sympathetic neuron survival by synergistic action of NT3 and GDNF. Neuroreport, 2000, 11(11), 2541-2545.
68. Wilson-Gerwing, T.D.; Dmyterko, M.V.; Zochodne, D.W.; Johnston, J.M.; Verge, V.M. Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J. Neurosci., 2005, 25(3), 758-767.
69. Park, S.Y.; Choi, J.Y.; Kim, R.U.; Lee, Y.S.; Cho, H.J.; Kim, D.S. Downregulation of voltage-gated potassium channel alpha gene expression by axotomy and neurotrophins in rat dorsal root ganglia. Mol. Cells, 2003, 16(2), 256-259.
70. Bradbury, E.J.; Khemani, S.; Von R., King; Priestley, J.V.; McMahon, S.B. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur. J. Neurosci., 1999, 11(11), 3873-3883.
71. Siniscalco, D.; de Novellis, V.; Rossi, F.; Maione, S. Neuropathic pain: is the end of suffering starting in the gene therapy? Curr. Drug Targets, 2005, 6(1), 75-80.
72. Pradat, P.F.; Kennel, P.; Naimi-Sadaoui, S.; Finiels, F.; Orsini, C.; Revah, F.; Delaere, P.; Mallet, J. Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies. Hum. Gene Ther., 2001, 12(18), 2237-2249.
73. White, DM. Neurotrophin-3 antisense oligonucleotide attenuates nerve injury-induced Abeta-fibre sprouting. Brain Res., 2000, 885(1), 79-86.
74. Minichiello, L.; Casagranda, F.; Tatche, R.S.; Stucky, C.L.; Postigo, A.; Lewin, G.R.; Davies, A.M.; Klein, R. Point mutation in trkB causes loss of NT-4 dependent neurons without major effects on diverse BDNF responses. Neuron, 1998, 21, 335-345.
75. Thornton, M.R.; Shawcross, S.G.; Mantovani, C.; Kingham, P.J.; Birchall, M.A.; Terenghi, G. Neurotrophins 3 and 4 differentially regulate NCAM, L1 and N-cadherin expression during peripheral nerve regeneration. Biotechnol. Appl. Biochem., 2008, 49(Pt 2), 165-174.
76. Yin, Q.; Kemp, G.J.; Yu, L.G.; Wagstaff, S.C.; Frostick, S.P. Expression of Schwann cell-specific proteins and low-molecularweight neurofilament protein during regeneration of sciatic nerve treated with neurotrophin-4. Neuroscience, 2001, 105(3), 779-783.